Willis Towers Watson (WLTW) Reports Q4 EPS of $2.40, Revenues Miss
Get Alerts WLTW Hot Sheet
Join SI Premium – FREE
Willis Towers Watson (NASDAQ: WLTW) reported Q4 EPS of $2.40, versus $4.06 reported last year. Revenue for the quarter came in at $2.37 billion versus the consensus estimate of $2.38 billion.
Excluding the Revenue Standard Impact
- Reported Revenue increased 3% for the quarter and 5% for the year
- Organic Revenue increased 6% for the quarter and 5% for the year
- Diluted Earnings per Share were $1.29 for the quarter and $5.87 for the year
- Adjusted Diluted Earnings per Share were $2.40 for the quarter and $10.33 for the year
- Cash flows from operating activities was $1.3 billion, up 55% over prior year
- Free Cash Flow was $1.1 billion, up 90% over prior year
Including the Revenue Standard Impact
- Reported Revenue was $2.4 billion for the quarter and $8.5 billion for the year
- Diluted Earnings per Share were $2.89 for the quarter and $5.27 for the year
- Adjusted Diluted Earnings per Share were $4.00 for the quarter and $9.73 for the year
- Cash flows from operating activities was $1.3 billion
- Free Cash Flow was $1.0 billion
“Our performance this quarter provided an outstanding finish to a strong year,” said John Haley, Willis Towers Watson’s chief executive officer. “We are very pleased with our progress in 2018. We concluded our integration efforts and delivered on our financial commitments; with strong top line growth, meaningful profitability improvement and robust cash flow growth. This momentum, combined with our continued focus on executing our strategy, leaves us very well-positioned for another year of operational success and driving shareholder value.”
For earnings history and earnings-related data on Willis Towers Watson (WLTW) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Vivos Therapeutics posts 35% revenue gain but widens net loss
- Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
Create E-mail Alert Related Categories
Corporate News, Earnings, Management CommentsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share